When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Abandono do hábito de fumar

Última revisión: 27 Nov 2025
Última actualización: 23 Oct 2025

Resumen

Definición

Anamnesis y examen

Principales factores de diagnóstico

  • número de cigarros por dia
  • tempo até o primeiro cigarro (TTFC)
  • uso de produtos alternativos de administração de tabaco e nicotina
  • história de transtorno relacionado ao uso de substâncias
  • gestação ou amamentação
Todos los datos

Otros factores de diagnóstico

  • história de depressão
  • história de esquizofrenia
  • transtorno convulsivo
  • hipertensão
  • doença cardíaca instável
  • arritmia ventricular
  • asma
  • doença pulmonar obstrutiva crônica (DPOC)
  • distúrbio da articulação temporomandibular ou problema dentário
Todos los datos

Factores de riesgo

  • idade <24 anos
  • condição socioeconômica baixa
  • história de transtorno mental ou transtorno por uso de substâncias
  • história de HIV/AIDS
  • uso de produtos alternativos de administração de tabaco e nicotina
  • genética
Todos los datos

Pruebas diagnósticas

Primeras pruebas diagnósticas para solicitar

  • autorrelato da condição de fumante
  • Teste de Fagerström para a dependência de nicotina (Fagerström Test For Nicotine Dependence; FTND)
  • Índice de Intensidade do Tabagismo (Heaviness of Smoking Index; HSI)
Todos los datos

Pruebas diagnósticas que deben considerarse

  • monitoramento do monóxido de carbono (CO)
  • nível de cotinina
Todos los datos

Algoritmo de tratamiento

Agudo

fumantes ativos hospitalizados

En curso

fumantes ativos prontos para parar: adultos (não gestantes/lactantes)

fumantes ativos dispostos a parar: gestantes/lactantes ou adolescentes

fumantes ativos não dispostos a parar

Colaboradores

Autores

Franck F. Rahaghi, MD, MHS, FCCP

Chairman

Pulmonary Department

Director

Pulmonary Education and Rehabilitation

Cleveland Clinic

Weston

FL

Divulgaciones

FFR is a consultant and speaker for Bayer, United Therapeutics, Janssen-PH, Merck, Boehringer Ingleheim, Takeda, and Talecris. He is involved in industry-sponsored research with Bayer, Janssen-PH, Gossamer Bio, and Bellerophon.

Samuel Gurevich, MD, FCCP

Pulmonary Department

Director

Respiratory Therapy

Cleveland Clinic

Weston

FL

Divulgaciones

SG declares that he has no competing interests.

Agradecimientos

Dr Franck F. Rahaghi and Dr Samuel Gurevich would like to gratefully acknowledge Dr Felix Hernandez, Dr Jose Gonzalez, and Dr Theodore W. Marcy, previous contributors to this topic.

Divulgaciones

FH, JG, and TWM declare that they have no competing interests.

Revisores por pares

Jaymin Morjaria, MBBS, FRCP, MD

Consultant Respiratory Physician

Guy’s and St Thomas NHS Foundation Trust

Harefield Hospital

Middlesex

Honorary Senior Lecturer

Brunel University

London

UK

Divulgaciones

JM has received honoraria for speaking and financial support to attend meetings/advisory boards from Wyeth, Chiesi, Pfizer, MSD, Boehringer Ingelheim, Teva, GSK/Allen & Hanburys, Napp, Almirall, AstraZeneca, Trudell, Cook Medical, Medela AG, Medtronics, and Novartis. He has been an expert witness in a court case relating to the impact of smoking on illness severity, ITU admissions, and mortality from Covid-19 in South Africa in 2020.

Arran Woodhouse, MSc

Senior Tobacco Programme Manager

North Central London Integrated Care Board

London

UK

Divulgaciones

AW has been reimbursed by Johnson & Johnson Ltd Nicorette UK Consulting for chairing the Smoking Cessation National Advisory Panel on 1 November 2022. He worked with NICE on the recent Tobacco Guideline (NG209) as a topic expert and as a specialist committee member for the treating dependence Quality Standards Advisory Committee (QS 207). He was appointed as an Expert Adviser for the NICE Centre for Guidelines in February 2023. Previous member of the British Thoracic Society's Tobacco Specialist Advisory Group.

Agradecimiento de los revisores por pares

Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.

Divulgaciones

Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

United States Public Health Service Office of the Surgeon General; National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. Smoking cessation: a report of the Surgeon General. 2020 [internet publication].Texto completo  Resumen

Tobacco Use and Dependence Guideline Panel, US Department of Health and Human Services. Treating tobacco use and dependence: 2008 update. Rockville (MD): US Department of Health and Human Services; 2008.Texto completo

National Institute for Health and Care Excellence. Tobacco: preventing uptake, promoting quitting and treating dependence. Feb 2025 [internet publication].Texto completo

US Preventive Services Task Force. Interventions for tobacco smoking cessation in adults, including pregnant persons: US Preventive Services Task Force recommendation statement. JAMA. 2021 Jan 19;325(3):265-79.Texto completo  Resumen

Barua RS, Rigotti NA, Benowitz NL, et al. 2018 ACC expert consensus decision pathway on tobacco cessation treatment: a report of the American College of Cardiology Task Force on clinical expert consensus documents. J Am Coll Cardiol. 2018 Dec 5;72(25):3332-65.Texto completo  Resumen

Hartmann-Boyce J, Chepkin SC, Ye W, et al. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev. 2018 May 31;(5):CD000146.Texto completo  Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
  • Abandono do hábito de fumar images
  • Diferenciales

    • Transtorno relacionado ao uso de substâncias
    Más Diferenciales
  • Guías de práctica clínica

    • Tobacco: preventing uptake, promoting quitting and treating dependence
    • NCCN clinical practice guidelines in oncology: smoking cessation
    Más Guías de práctica clínica
  • Folletos para el paciente

    Abandono do hábito de fumar

    Más Folletos para el paciente
  • padlock-lockedInicie sesión o suscríbase para acceder a todo el BMJ Best Practice

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad